Dataset Information


Vimentin expression is required for the development of EMT-related renal fibrosis following unilateral ureteral obstruction in mice.

ABSTRACT: Most renal transplants ultimately fail secondary to chronic allograft nephropathy (CAN). Vimentin (vim) is a member of the intermediate filament family of proteins and has been shown to be important in the development of CAN. One of the pathways leading to chronic renal fibrosis after transplant is thought to be epithelial to mesenchymal transition (EMT). Even though vim expression is one of the main steps of EMT, it is unknown whether vim expression is required for EMT leading to renal fibrosis and allograft loss. To this end, the role of vim in renal fibrosis was determined via unilateral ureteral obstruction (UUO) in vim knockout mice (129 svs6 vim -/-). Following UUO, kidneys were recovered and analyzed via Western blotting, immunofluorescence, and transcriptomics. Cultured human proximal renal tubular (HK-2) cells were subjected to lentiviral-driven inhibition of vim expression and then treated with transforming growth factor (TGF)-? to undergo EMT. Immunoblotting as well as wound healing assays were used to determine development of EMT. Western blotting analyses of mice undergoing UUO reveal increased levels of vim soon after UUO. As expected, interstitial collagen deposition increased in control mice following UUO but decreased in vim -/- kidneys. Immunofluorescence analyses also revealed altered localization of ?-catenin in vim -/- mice undergoing UUO without significant changes in mRNA levels. However, RNA sequencing revealed a decrease in ?-catenin-dependent genes in vim -/- kidneys. Finally, vim-silenced HK-2 cell lines undergoing EMT were shown to have decreased cellular migration during wound healing. We conclude that vim inhibition decreases fibrosis following UUO by possibly altering ?-catenin localization and downstream signaling.


PROVIDER: S-EPMC6335003 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC4141797 | BioStudies
2020-01-01 | S-EPMC7039973 | BioStudies
2019-01-01 | S-EPMC6520492 | BioStudies
1000-01-01 | S-EPMC4846896 | BioStudies
1000-01-01 | S-EPMC6156234 | BioStudies
2019-01-01 | S-EPMC6536582 | BioStudies
1000-01-01 | S-EPMC5507915 | BioStudies
2019-01-01 | S-EPMC6653435 | BioStudies
2014-01-01 | S-EPMC5380014 | BioStudies
2015-01-01 | S-EPMC4456380 | BioStudies